Home > Boards > US Listed > Biotechs > Cytokinetics, Inc. (CYTK)

News: $CYTK Cytokinetics Announces Receipt of FDA Feedback

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 57
Posts 7,770
Boards Moderated 0
Alias Born 06/04/18
160x600 placeholder
Cytokinetics to Host Virtual Investor & Analyst Day on July 15, 2020 GlobeNewswire Inc. - 7/1/2020 4:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 5:00:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2020 5:44:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2020 6:08:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 5:58:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:32:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:32:05 PM
Cytokinetics to Participate In Upcoming Investor Conferences GlobeNewswire Inc. - 6/8/2020 4:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 7:45:44 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/29/2020 4:09:10 PM
Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS GlobeNewswire Inc. - 5/27/2020 7:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2020 5:05:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2020 5:04:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/18/2020 7:38:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 4:01:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/12/2020 4:22:59 PM
Cytokinetics Shares Jump After FDA Fast Track Designation for Omecamtiv Mecarbil Dow Jones News - 5/11/2020 10:44:00 AM
whytestocks Member Level  Tuesday, 01/22/19 07:41:50 AM
Re: None
Post # of 1491 
News: $CYTK Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA

SOUTH SAN FRANCISCO, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it has received feedback from the U.S. Food and Drug Administration (FDA) that the Six Minute Walk Test (6MWT) is an acceptable primary efficacy endpoint for a poten...

Read the whole news https://marketwirenews.com/news-releases/cytokinetics-announces-receipt-of-fda-feedback-regarding-reldesemtiv-in-patients-with-sma-7414652.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist